ArticleCancer research2014

FLT3 kinase inhibitor TTT-3002 overcomes both activating and drug resistance mutations in FLT3 in acute myeloid leukemia.

Hayley S Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.